Neuropathologic Substrate of Mild Cognitive Impairment

William R. Markesbery, Frederick A. Schmitt, Richard J. Kryscio, Daron G. Davis, Charles D. Smith, David R. Wekstein

Archives of Neurology · 2006 · 459 citations · 32 references

Abstract

In patients with amnestic MCI who were followed longitudinally, the early changes of Alzheimer disease were present. The NFTs were slightly more prominent than beta-amyloid peptide deposition in the progression from normal to MCI to EAD. Ventromedial temporal lobe NFTs probably represent the substrate for memory decline in MCI. From a neuropathologic perspective, it appears that amnestic MCI is, in reality, EAD.

References

32